• • In late 2021, Software Effective Solutions Corp. dba MedCana acquired five companies with licenses to produce, process, and export cannabis with and without T.H.C. The purchased companies have a combined total area of 105 Acres (42.84 Hectares). MedCana has also secured the option to expand operations to an additional 177 Acres (72 Hectares) as needed.
  • The primary area of operation is outside of Marinilla, a small town approximately one hour away from Medellin in the department of Antioquia, Colombia. Initial design as well as all environmental, geological, and hydrological have been completed and the project will be ready to break ground in June of 2023.
  • In September 2022, MedCana also acquired Tokan Corp’s assets, a software company, with the focus of creating an ERP platform for the cannabis industry to track the seed to patient process.
  • In October of 2022, MedCana acquired Eko2O S.A.S. a company focused on design and distribution of greenhouses and advanced irrigation platforms. The track record, experience, and industry knowledge that CEO Juan Ricardo Velez brings has set the company up for explosive growth in the region while also dramatically decreasing costs for MedCana’s subsidiaries in the region.

SFWJ CEO Gabriel Diaz states, “We are extremely pleased with the progress we’ve made in the past several months. We look forward to updating shareholders, and are committed to doing everything possible to increase shareholder value.”

ABOUT SFWJ: 

Software Effective Solutions/MedCana is a global infrastructure and holding company in the cannabis industry. Currently, MedCana has five companies focused on pharmaceutical cannabis production, one software company focused on managing processes for plant-to-patient operations. The recent acquisition an irrigation and greenhouse technology company has rounded out MedCana’s portfolio of companies. MedCana’s initial focus is on developing clients and companies in Latin America with an initial focus in Colombia and partnerships with laboratories, research facilities, and hospitals throughout the world.

SAFE HARBOR STATEMENT

This press release contains forward-looking statements that can be identified by terminology such as “believes,” “expects,” “potential,” “plans,” “suggests,” “may,” “should,” “could,” “intends,” or similar expressions. Many forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results to be materially different from any future results implied by such statements. These factors include, but are not limited to, our ability to continue to enhance our products and systems to address industry changes, our ability to expand our customer base and retain existing customers, our ability to effectively compete in our market segment, the lack of public information on our company, our ability to raise sufficient capital to fund our business, operations, our ability to continue as a going concern, and a limited public market for our common stock, among other risks. Many factors are difficult to predict accurately and are generally beyond the company’s control. Forward-looking statements speak only as to the date they are made, and we do not undertake to update forward-looking statements to reflect circumstances or events that occur after the date the forward-looking statements are made.

Contact:

Jose Gabriel Diaz, CEO

www.medcana.net

info@medcana.co

Contact Details

MedCana

info@medcana.co

Company Website

https://www.medcana.net/

NEWTOWN, PA and DEERFIELD BEACH, FL, Feb. 13, 2023 (GLOBE NEWSWIRE) — via NewMediaWire — Forian Inc. (Nasdaq: FORA), a provider of technology, analytics and data science driven solutions, today announced the sale of Forian’s cannabis software subsidiary, Bio-Tech Medical Software, Inc. (d/b/a BioTrack), to Alleaves, Inc., a provider of ERP software solutions to the cannabis industry, effective February 10, 2023, for a total purchase price of $30 million in cash, comprised of $20 million paid at closing and $10 million paid in twelve required equal monthly installments, subject to any working capital adjustments. Forian will retain a license to certain cannabinoid-based data to enhance its healthcare information offerings. As a result of the transaction, Forian will focus on its healthcare information business and will no longer provide software solutions to the cannabis industry.

“This transaction allows us to focus our efforts on our healthcare information business, which has been the key driver of our growth to date and will further accelerate our path to positive Adjusted EBITDA,” said Max Wygod, Executive Chairman of Forian.

The acquisition by Alleaves adds industry leading point of sale and traceability platforms within the cannabis industry, including BioTrack and Cannalytics^®, to the Alleaves offering suite.

“The addition of BioTrack and Cannalytics will accelerate our mission to provide top-of-the-line ERP solutions to the cannabis industry,” said Mike Beedles, Founder of Alleaves. “I’m especially encouraged for our current and future clients who will benefit from having access to two leading cannabis software organizations, both of which are dedicated to our customers’ need for improved control, cohesion, clarity and compliance in this vast and evolving industry.”

Simultaneous with the transaction, Daniel Barton stepped down as Chief Executive Officer and President of Forian effective February 10, 2023. Max Wygod, Forian’s co-founder and Executive Chairman, has been appointed Interim Chief Executive Officer and President. “On behalf of the Board, I want to thank Dan for his dedication to and leadership of Forian,” commented Max Wygod.

About Forian

Forian Inc. provides a unique suite of data management capabilities and proprietary data and analytics to optimize and measure operational, clinical and financial performance for customers within the traditional and emerging life sciences, healthcare payer and provider segments. For more information, please visit Forian’s website at www.forian.com.

About Alleaves

Alleaves was founded with a knowledge of cannabis cultivation, manufacturing, and sale embedded in the company’s culture. Its ultimate goal is to optimize the unique complexity of the cannabis journey affecting its operator customers, with a top-of-the-line ERP platform, focusing on the flexibility for customers to choose elements of its cohesive system designed to improve cannabis operator business operations. For more information, please visit Alleaves’ website at www.alleaves.com.

Cautionary Statements Regarding Forward-Looking Statements

This release contains “forward-looking statements” within the meaning of the federal securities laws, including Section 27A of the Securities Act and Section 21E of the Securities Exchange Act of 1934, as amended. In this context, forward-looking statements often address expected future business and financial performance and financial condition, and often contain words such as “expect,” “anticipate,” “intend,” “plan,” “believe,” “seek,” “see,” “will,” “would,” “target,” similar expressions and variations or negatives of these words. Forward-looking statements by their nature address matters that involve risks and uncertainties, many of which are beyond the control of Forian, and are not guarantees of future results, such as statements about the anticipated benefits of the transaction announced, future financial and operating results, company strategy and intended product offerings and market positioning. These and other forward-looking statements are not guarantees of future results and are subject to risks, uncertainties and assumptions that could cause actual results to differ materially from those expressed in any forward-looking statements. Accordingly, there are or will be important factors that could cause actual results to differ materially from those indicated in such statements and, therefore, you should not place undue reliance on any such statements and caution must be exercised in relying on forward-looking statements. Factors that could cause actual results to differ include, but are not limited to, those risks and uncertainties associated with: the impact of the COVID-19 pandemic on Forian’s business, operations, strategy and goals; Forian’s ability to execute on its strategy; the timing of the introduction of new product offerings; and the additional risks and uncertainties set forth more fully under the caption “Risk Factors” in Forian’s Annual Report on Form 10-K for the year ended December 31, 2021, as filed with the SEC on March 31, 2022, and elsewhere in Forian’s filings and reports with the SEC. Forward-looking statements contained in this announcement are made as of the date hereof, and Forian undertakes no duty to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required under applicable law.

Forian Media and Investor Contact:
forian.com/investors
[email protected]
267-225-6263

Alleaves Media Contact:
Michael Alfonso
[email protected]
321-987-9018

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as “expects”, “will”, “anticipates”, and “estimates”; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief “snapshot” of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled “Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

<!– (adsbygoogle = window.adsbygoogle || []).push({ google_ad_client: “ca-pub-5707738102681835”, enable_page_level_ads: true }); –>

<!– Click –>

<!– (adsbygoogle = window.adsbygoogle || []).push({ google_ad_client: “ca-pub-5707738102681835”, enable_page_level_ads: true }); –>

<!– Click –>

<!– (adsbygoogle = window.adsbygoogle || []).push({ google_ad_client: “ca-pub-5707738102681835”, enable_page_level_ads: true }); –>

<!– Click –>

Leading East Coast Event, Nov. 4-6, Offers Best in Class Insider Information and Thought Leadership Series

(Paramus, NJ, October 2021)—New York, and the tri-state area, is primed to become a business epicenter for the legalized cannabis and hemp industry, and the CWCBExpo (Cannabis World Congress & Business Exposition), November 4-6 at the Javits Convention Center, in New York City, offers an in-depth educational program on this multi-faceted and complex industry.

Hosted by Geoff Whaling, Chair of the National Hemp Association and Matthew Anderson, Founder & CEO of Vanguard Scientific, “Inside the Industry: Thought Leadership Series,” will be an interactive “Talk Show” format and feature some of the most influential and informed minds in the cannabis and hemp industry. They will share their unique insight and provide actionable information and guidance on how to navigate and succeed in this dynamic industry. This forward-thinking format will take a deep dive into the state of the industry today on day one, discuss its challenges and provide solutions on day two, and project what’s next for this burgeoning industry on day three.

“There will be, yet again, a number of firsts at CWCBExpo,” said Geoff Whaling. “The new interactive format combined with many new faces, will provide attendees with a fresh inside expert look at our industry and its growing potential.”

The latest on New York State’s, and surrounding states’, adult use legalization as well as relevant content and informational panels on cultivation, licensing, social equity, environmental issues, raising capital, Marijuana Recreational Taxation Act (MRTA), marketing/branding, and more will be part of the Thought Leadership Series.

“The cannabis and hemp industries are developing their own unique and separate subsectors. As each of these open for business, they too will face their own maturing processes that will yield some of the most crucial global advancements we will see in the coming years. This engaging Conference Series format will allow for collaborative discussion and proactive advancement of some of the most challenging as well as important areas of growth,” added Matthew Anderson.

As hosts of the 3-day Thought Leadership Series at CWCBExpo, Whaling and Anderson will kick-off each day by setting the stage with the day’s agenda and recapping what was discussed the previous day and providing essential takeaways.

Cowen’s Gerald Pascarelli, CFA, Vice President, Consumer-Beverages, Cannabis & Tobacco, will deliver an industry update for cannabis and hemp that includes analysis of consumption, purchasing habits, marketing spend, as well as demographic and social data in the USA and across the globe on November 4^th to kick off the CWCBExpo Conference Program.  There will also be a Keynote: In Conversation with social entrepreneurs and New York cannabis legalization advocates, Christopher “CJ” Wallace and Willie Mack, Co-Founders of Think BIG & Frank White.

Another Keynote Panel will take place on Nov. 6^th  featuring Faye Coleman of Pure Genesis and Calvin Frye of Cloneville Compassionate Caregivers, both Multi-State Operators, sharing their coast-to-coast perspectives and experiences as entrepreneurs. The CWCBExpo Conference Program is sponsored by Vincente Sederberg, LLP.

CWCBExpo New York will also have a dynamic expo floor on the expansive third level of the Javits Center (Hall 3A). The most innovative product, service and technology companies will showcase their solutions for the entire cannabis ecosystem.

Active outreach and collaboration with community organizations, non-profits and cultural events in the New York and tri-state region is underway to create the most engaging CWCBExpo Cannabis Week for all stakeholders in the growing East Coast market.

To register and secure the best pre-show pricing go to:
https://cwcbexpo.com/registration_ny.  For more information on limited prime exhibit space and sponsorship opportunities, email: [email protected] or call 201-580-2050.

###

About Cannabis World Congress & Business Exposition (CWCBExpo)

CWCBExpo is a business-to-business trade show event for the legalized cannabis and hemp industry. It is held in the largest business, financial, and media markets. It is the leading forum for dispensary owners, growers, suppliers, investors, medical professionals, government regulators, legal counsel, and entrepreneurs looking to achieve business success and identify new areas of growth in this dynamic and fast-growing industry. Visit: www.cwcbexpo.com.

Editor’s Note:  Qualified members of the media are invited to register as press for CWCBExpo New York, email: [email protected]

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.

<!– (adsbygoogle = window.adsbygoogle || []).push({ google_ad_client: “ca-pub-5707738102681835”, enable_page_level_ads: true }); –>

<!– Click –>

<!– (adsbygoogle = window.adsbygoogle || []).push({ google_ad_client: “ca-pub-5707738102681835”, enable_page_level_ads: true }); –>

<!– Click –>

<!– (adsbygoogle = window.adsbygoogle || []).push({ google_ad_client: “ca-pub-5707738102681835”, enable_page_level_ads: true }); –>

<!– Click –>